Journal of Personalized Medicine

Scope & Guideline

Innovating personalized therapies for optimal patient outcomes.

Introduction

Welcome to the Journal of Personalized Medicine information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Journal of Personalized Medicine, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN-
PublisherMDPI
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationJ PERS MED / J. Pers. Med.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND

Aims and Scopes

The Journal of Personalized Medicine focuses on advancing individualized healthcare through precision medicine approaches in clinical practice, research, and education. It aims to disseminate knowledge that bridges the gap between genetic, molecular, and clinical aspects of patient care.
  1. Precision Medicine Applications:
    The journal emphasizes innovative approaches that tailor medical treatment to individual patient characteristics, including genomic profiles, environmental factors, and lifestyle.
  2. Clinical Trials and Research Methodologies:
    It publishes studies that explore the efficacy and safety of personalized treatment protocols, including randomized controlled trials, cohort studies, and systematic reviews.
  3. Interdisciplinary Collaboration:
    The journal promotes research that integrates multiple medical disciplines, highlighting the importance of collaboration among healthcare professionals to enhance patient outcomes.
  4. Emerging Technologies in Medicine:
    Focus is placed on the application of advanced technologies, such as artificial intelligence, machine learning, and bioinformatics, to improve diagnostic accuracy and treatment efficacy.
  5. Patient-Centered Care:
    The journal emphasizes the importance of understanding patient preferences, experiences, and health literacy in the development and implementation of personalized treatment plans.
The Journal of Personalized Medicine is witnessing exciting trends and emerging themes in the field of personalized healthcare. These developments highlight the increasing complexity and interconnectedness of patient care, reflecting advances in technology and a deeper understanding of individual variability.
  1. Integrative Omics Approaches:
    There is a growing trend in the utilization of multi-omics data (genomics, proteomics, metabolomics) to tailor treatments and predict patient outcomes in various diseases.
  2. Artificial Intelligence and Machine Learning:
    The incorporation of AI and machine learning in clinical decision-making, predictive modeling, and data analysis is rapidly increasing, showcasing the journal's focus on technology-driven healthcare.
  3. Telemedicine and Remote Monitoring:
    The COVID-19 pandemic has amplified interest in telemedicine, leading to an increase in studies exploring its effectiveness in personalized care, particularly in chronic disease management.
  4. Patient Engagement and Shared Decision-Making:
    There is an emerging emphasis on involving patients in their care decisions, reflecting a shift towards a more collaborative approach in personalized medicine.
  5. Mental Health and Personalized Interventions:
    Research focusing on personalized treatment plans for mental health disorders is gaining traction, addressing the need for individualized approaches in psychological care.

Declining or Waning

While the Journal of Personalized Medicine continues to explore various themes, some areas of research seem to be declining in frequency or relevance over recent years. This trend may reflect shifts in focus towards more pressing contemporary health challenges or advancements in technology.
  1. Traditional One-Size-Fits-All Approaches:
    There is a noticeable decline in publications focused on generalized treatment protocols, as the emphasis shifts towards more personalized strategies that account for individual patient variability.
  2. Basic Science without Clinical Application:
    Research that does not directly translate into clinical practice or lacks clear implications for patient care appears to be less prevalent, as the journal prioritizes studies with direct patient impact.
  3. Single-Disease Focus Studies:
    There is a waning interest in studies solely concentrating on single diseases without considering comorbidities or the broader context of personalized medicine.
  4. Pharmacogenetics as a Standalone Focus:
    While pharmacogenetics remains important, the journal has seen a decrease in papers solely dedicated to this topic, as more integrated approaches to genomics and patient care are favored.
  5. Outdated Technologies in Diagnostics:
    Research employing older diagnostic technologies without advancements or integration with modern tools is becoming less common, reflecting the journal's commitment to innovation.

Similar Journals

JOURNAL OF CLINICAL ONCOLOGY

Elevating the standards of cancer research and therapeutics.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0732-183XFrequency: 36 issues/year

Journal of Clinical Oncology is a premier academic journal published by Lippincott Williams & Wilkins, dedicated to the field of oncology and cancer research. Since its inception in 1983, this influential journal has consistently ranked in the Q1 category across multiple disciplines, including cancer research, medicine, and oncology, reflecting its critical role in shaping the future of cancer therapeutics and patient care. With a Scopus ranking of #9 in Medicine - Oncology and #6 in Biochemistry, Genetics and Molecular Biology - Cancer Research, Journal of Clinical Oncology publishes cutting-edge original research, reviews, and clinical updates that are essential for professionals, researchers, and students alike. Although it does not currently offer open access options, it provides invaluable insights and evidence-based findings that are crucial for advancing oncological knowledge and improving patient outcomes globally. The journal’s continued commitment to excellence ensures its place as a vital resource in the oncological community.

Precision and Future Medicine

Transforming healthcare with precision and insight.
Publisher: SUNGKYUNKWAN UNIV SCH MEDICINEISSN: 2508-7940Frequency: 4 issues/year

Precision and Future Medicine is an esteemed academic journal published by Sungkyunkwan University School of Medicine, dedicated to advancing the fields of precision medicine and healthcare innovation. Established as an Open Access journal in 2017, it aims to disseminate cutting-edge research and insights that bridge the gap between basic and clinical sciences. With a focus on personalized medicine, genomics, and advanced therapeutic strategies, the journal serves as a vital resource for researchers, clinicians, and policy makers. Set in the dynamic environment of South Korea, Precision and Future Medicine provides a platform for the exchange of ideas that are shaping the future of medical science, thus contributing significantly to the global dialogue on health and wellness. As it continues to grow, the journal is committed to ensuring that high-quality research remains accessible to all, fostering a spirit of collaboration and innovation within the scientific community.

Nature Reviews Clinical Oncology

Elevating Understanding, Empowering Treatments
Publisher: NATURE PORTFOLIOISSN: 1759-4774Frequency: 12 issues/year

Nature Reviews Clinical Oncology is a premier journal dedicated to the comprehensive exploration and critical evaluation of current advancements in the field of clinical oncology. Published by the esteemed NATURE PORTFOLIO in the United Kingdom, this influential journal boasts an impressive impact factor that reflects its significant role in shaping oncology research. As a Q1 ranked journal in Scopus, it occupies a notable position within the top tier of oncology publications, placing it in the 99th percentile among its peers. With a history of convergence from 2009 to 2024, it presents high-quality content through an open-access model, ensuring accessibility to vital research findings. Researchers, professionals, and students alike will find Nature Reviews Clinical Oncology an invaluable resource for staying abreast of the latest trends, biologic insights, and therapeutic innovations that drive the future of cancer treatment.

Precision Clinical Medicine

Empowering personalized medicine for every patient.
Publisher: OXFORD UNIV PRESSISSN: 2096-5303Frequency: 4 issues/year

Precision Clinical Medicine, published by Oxford University Press, is an esteemed open-access journal that has been at the forefront of clinical research since its inception in 2018. With an ISSN of 2096-5303, this journal specializes in the rapidly evolving field of precision medicine, which aims to tailor healthcare to individual patient characteristics, needs, and preferences. As a testament to its influence, Precision Clinical Medicine holds a remarkable rank of #34 out of 636 in the General Medicine category on Scopus, placing it within the 94th percentile of its field and earning a prestigious Q1 rating in 2023. Based in the United Kingdom, the journal not only provides open access content, ensuring that groundbreaking research is widely disseminated, but also serves as a crucial platform for innovations and discussions that shape modern medical practices. Researchers, professionals, and students alike will find valuable insights and influential studies that drive the future of personalized healthcare within its pages.

Onkologie

Fostering Knowledge and Innovation in Cancer Treatment.
Publisher: SPRINGER HEIDELBERGISSN: 2731-7226Frequency: 12 issues/year

Onkologie is a peer-reviewed academic journal published by SPRINGER HEIDELBERG, focusing on the evolving fields of Oncology and Hematology. Established as a significant platform for the dissemination of research in these crucial areas of medicine, Onkologie aims to provide insights into the latest advancements, therapeutic strategies, and clinical practices that shape patient care in oncology and hematology. Despite its current placement in the Q4 category for both disciplines, this journal aspires to foster scholarly dialogues and enhance its contributions to the scientific community. The journal is based in Germany and encourages submissions that promote a deeper understanding of oncology's complex landscape, ensuring that researchers, clinicians, and students have access to a wealth of knowledge essential for clinical practice and further research. With an ISSN of 2731-7226 and E-ISSN of 2731-7234, Onkologie is committed to maintain high standards in publication and peer review, driving innovation and discovery in the fields it represents.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Empowering Healthcare through Insightful Research
Publisher: WILEY-HINDAWIISSN: 1368-5031Frequency: 1 issue/year

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE is a premier peer-reviewed academic journal published by WILEY-HINDAWI, dedicated to advancing the field of clinical medicine. With an ISSN of 1368-5031 and E-ISSN 1742-1241, this open access journal has been providing a platform for insightful research since its inception in 1997 and continues to contribute significantly to the medical community, as indicated by its Q2 ranking in Medicine (miscellaneous) for 2023 and its position in the top 15% of Scopus-ranked journals. The journal invites innovative studies, systematic reviews, and clinical trials, making it a critical resource for healthcare professionals, researchers, and students seeking to stay updated on the latest clinical practices. Based in the United Kingdom at Adam House, 3rd Fl, 1 Fitzroy Sq, London W1T 5HE, this journal supports open accessibility, enhancing the dissemination of vital research findings across the globe. Join the growing community of scholars who contribute to and benefit from this influential publication as it continues to shape the future of clinical practice.

CHINESE MEDICAL JOURNAL

Championing high-quality research for better health outcomes.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0366-6999Frequency: 24 issues/year

CHINESE MEDICAL JOURNAL, published by Lippincott Williams & Wilkins, is a distinguished platform within the field of medicine, providing a vital forum for the dissemination of innovative research and clinical findings since its inception in 1946. With its open access model established in 2000, the journal ensures that critical medical advancements and insights are accessible to a global audience, fostering collaboration and continuous learning among researchers, healthcare professionals, and students alike. The journal’s impressive Q1 ranking in Medicine (miscellaneous), alongside its remarkable Scopus rank of #40 out of 636 in General Medicine, underscores its influential presence in the medical community, promoting high-quality research that advances health outcomes. As it converges historical and contemporary research, the CHINESE MEDICAL JOURNAL plays an essential role in bridging academic inquiry with practical medical application, emphasizing its commitment to improving global healthcare through rigorous scholarship and excellence.

Clinical and Investigative Medicine

Elevating medical knowledge through rigorous investigation.
Publisher: CANADIAN SOC CLINICAL INVESTIGATIONISSN: 0147-958XFrequency: 4 issues/year

Clinical and Investigative Medicine is a prestigious journal dedicated to advancing the fields of clinical research and medical practice, published by the Canadian Society for Clinical Investigation. With a history of insightful contributions since its inception in 1978, the journal serves as a vital platform for researchers, clinicians, and healthcare professionals to disseminate innovative findings and explore critical issues facing contemporary medicine. Housed within the Q3 quartile of the Medicine category, it boasts an impressive Scopus ranking of #280/636, placing it within the 56th percentile amongst its peers. Although it operates on a subscription basis, the journal remains accessible to a broad audience interested in comprehensive reviews, original research, and cutting-edge methodology, ensuring that vital information reaches a global readership. Submit your research to Clinical and Investigative Medicine and contribute to the ongoing dialogue that shapes the future of patient care and medical innovation.

BRITISH JOURNAL OF HOSPITAL MEDICINE

Exploring the forefront of hospital medicine since 1996.
Publisher: MA HEALTHCARE LTDISSN: 1750-8460Frequency: 12 issues/year

BRITISH JOURNAL OF HOSPITAL MEDICINE is a distinguished publication in the field of medicine, focusing primarily on the latest research, clinical practices, and advancements in hospital medicine. Published by MA HEALTHCARE LTD in the United Kingdom, this journal serves as a critical resource for healthcare professionals, researchers, and students alike, featuring insightful articles that bridge the gap between theory and practice. Holding a Q3 ranking in the miscellaneous medicine category and positioned within the top half of Scopus rankings, the journal underscores its commitment to high-quality, peer-reviewed content. With its inception dating back to 1996, the BRITISH JOURNAL OF HOSPITAL MEDICINE has evolved to include a broad spectrum of topics relevant to contemporary hospital settings, ensuring its readers are well-equipped with the knowledge necessary for improving patient care. Access options are tailored to modern readership, enhancing the visibility and dissemination of vital medical research.

ACADEMIC EMERGENCY MEDICINE

Elevating Research in Critical Care
Publisher: WILEYISSN: 1069-6563Frequency: 12 issues/year

ACADEMIC EMERGENCY MEDICINE, published by Wiley, stands as a leading journal in the field of emergency medicine, distinguished by its impressive rankings, including Q1 categories in both Emergency Medicine and Miscellaneous Medicine. With an ISSN of 1069-6563 and an E-ISSN of 1553-2712, the journal covers a broad array of topics relevant to emergency medicine, advancing research from its inception in 1994 up to 2024. Ranked #8 out of 109 in its category, this journal sits in the 93rd percentile according to Scopus, underscoring its significance and influence within the academic community. Although it does not currently offer open access options, its rigorous peer-review process and comprehensive publication standards ensure that only the highest quality research reaches its readership. Aimed primarily at researchers, practitioners, and students in the field, ACADEMIC EMERGENCY MEDICINE serves as an essential resource for those seeking to enhance their understanding and practice of emergency care, making significant contributions to both theory and clinical applications in the field.